Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.

Heart bypass surgery is a new beginning for patients, significantly enhancing longevity and quality of life. It is performed when critical blockages a ...

The Vietnam Controlled Release Drug Delivery Market was valued at USD 276.32 million in 2024 and is projected to reach USD 455.63 million by 2033, growing at a CAGR of 8.65% during the forecast period ...

New kit system enables selection of granule sizes suited for patient anatomy in real time BonVie+ is a calcium-salt ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and develops high-end products for orthopaedic surgery, covering the main ...

The global neurovascular device market is poised for steady expansion, with market valuation expected to reach USD 3.0 billion in 2024, according to the latest report by Future Market Insights. The ...

Collaboration between UOW, FivepHusion aims to improve treatment, outcomes for patients with pancreatic cancer Pancreatic ...

Q4 2024 Earnings Call Transcript March 6, 2025 Elutia Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.25. Operator: Good afternoon, ladies and gentlemen.

Glaucoma, a group of eye conditions that damage the optic nerve at the back of the eye, can lead to vision loss and even ...

Reports Q4 revenue $ $5.47M, consensus $5.9M.”Elutia (ELUT) closed out 2024 with the successful pilot launch of EluPro, the first ever ...